RF Plasma BPH Surgery Probe For Treatment of Urethral Stricture

Preoperative preparation

1. Definitive diagnosis;

2. Confirm that the patient has no operation contraindication. For example: Serious cardio cerebral vascular disease, emphysema with pulmonary infection,general hemorrhagic disease, serious diabetes, etc.;

3. Preoperative examination to understand the degree of urethremphraxis, whether the upper urinary tract is deformed or not and the prostate size.

Technical Parameters:

Features:

The PLA207 electrode is the gold standard design, used for the treatment of urethral stricture, continuous spot-cutting and shaping.

Product Characteristics:

• Using the low temperature plasma technology, minimize the injury to the surrounding tissue.
• Combined rare precious metals with NT.
• With precise and highly effective bipolar and multi-polar design, it improves the safety during the surgery.
• New design of the probe working tip, probe structure is exquisite, and fully meet the needs of clinical use.
• Integrated cable design, simple operation, to prevent cross contamination.
• With multi-point electrode working technology, temperature is dramatically lowered while highly effective ablation and cutting.
• Local anesthesia operation, convenient operation, safe, minimally invasive, good curative effect, quick recovery.

Cautions in operation

Have liquid diet at the second day after the operation.

Pull out the urethral catheter when the drainage urine is clear.

No drinking and no sex within one month after leaving hospital to prevent constipation.

Go back the hospital in time for return visit if there’s symptoms of urine pain, urgent urination, hematuria etc.

Chengdu Mechan Electronic Technology Co., Ltd.

Established in 2002, Mechan Medical is a high-tech medical enterprise with the integration of R&D, manufacture and marketing. It is the pioneer of research, development and manufacturing plasma medical products in mainland China. Mechan Medical is devoted to low-temperature plasma surgery system for minimally-invasive, and our products at present cover ENT, Orthopedics, Urology, Gynecology, Ophthalmology, Anorectal, etc.

The company has listed on the new third board on August 18, 2015, wherein the stock code is 833234 and the stock abbreviation is: Mechan Medical.

We has a strong record of medical sales and service network, including 31 provinces and cities nationwide, and our products are exported to over 10 countries,including Isreal, South Korea, Saudi Arabia, Iran, Brasizl, the United Arab Emirates, Indonesia etc. We have mastered the core technology of low temperature plasma through the cooperation of Томский политехнический университет and Shenyang Ligong University, and established the company Mechan Europe in UK.

In order to make the products go better out of the country and understand the international most advanced plasma minimally invasive medical technology, we and which means our quality is accepted by the European market.

In October 2014, obtained the qualification as a hi-tech enterprise

In November 2014, CE marked

In January 2015, got invention patent of Low temperature plasma technology

In May 2015, started to apply for the international patents in America and EU

Our vision is to become a professional company taking low temperature plasma technology as core to produce minimally invasive products for whole departments, and make the low-temperature plasma technology as the must tool for surgeons .

At the same time of perfecting ENT Products, we constantly develop our products for Orthopedics, Gynecology, Urology, Ophthalmology, Digestion, Anorectal, Plastic surgery, General surgery, and so on.

Our goal is to make Chengdu Mechan the leading pioneer of the low-temperature plasma products in China, and make the Company a famous and respected medical enterprise.